BackArtgen Biotech PJSC Overview

Artgen Biotech PJSC Current Assets

Artgen Biotech PJSC's current assets is $1.7B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$1.67B
↑ 698.60% YoYΔ $1.46B vs prior year quarter

Peer trimmed avg / median

Loading

Artgen Biotech PJSC Current Assets History

Loading

Artgen Biotech PJSC vs. peers: Current Assets Comparison

Loading

Artgen Biotech PJSC Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Artgen Biotech PJSC (ISKJ.ME) FAQ

Artgen Biotech PJSC's current assets stands at $1.7B as of June 2026. That compares with $210M in the prior-year period — up 698.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Artgen Biotech PJSC reported $1.7B in current assets versus $210M a year earlier — a 698.6% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $210M in the prior-year period — up 698.6% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Artgen Biotech PJSC's current assets evolved across reporting periods, while the comparison chart places ISKJ.ME next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current assets is commonly used to spot outliers. Artgen Biotech PJSC's reading of $1.7B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.